Literature DB >> 7864806

Phospholipase A2 from plasma of patients with septic shock is associated with high-density lipoproteins and C3 anaphylatoxin: some implications for its functional role.

M A Gijón1, C Pérez, E Méndez, M Sánchez Crespo.   

Abstract

Phospholipase A2 (PLA2) activity was purified 12,544-fold with a 13% yield from the plasma of patients diagnosed of septic shock by the sequential use of heparin-agarose affinity chromatography, gel filtration, and reverse-phase f.p.l.c. Gel-filtration chromatography of plasma omitting high-ionic-strength buffer revealed a molecular mass different from that of purified PLA2 and co-elution with apolipoprotein A-I peaks, which suggests its association with high-density lipoproteins (HDL). N-terminal analysis of the enzyme activity protein band, electroblotted from a SDS-acrylamide gel and with an assessed molecular mass of 19 kDa, showed an identical sequence to that of alpha-chain of human C3 complement component, suggesting the presence in this band of a complex formed by a complement C3-derived anaphylatoxin (C3a)-related fragment and the PLA2 linked side-by-side. Because the preparation of plasma enzyme showed lower activity than the enzyme obtained from fibroblasts transfected with the coding sequence of human group-II PLA2, and because the addition of C3-derived anaphylatoxins from human serum inhibited the activity of this recombinant PLA2, it was considered that C3a-related peptides behave as inhibitors of group-II PLA2. The enzyme showed optimal activity on [14C]oleate-labelled autoclaved E. coli, on synthetic phosphatidylethanolamine, and on [3H]arachidonate-labelled membranes of the monoblast cell line U937, but it did not show any activity on the release of [3H]arachidonate from pre-labelled human polymorphonuclear leukocytes (PMNs). In short, PLA2 from plasma of sepsis patients shows unique associations with other plasma proteins which may influence its functional properties. The association with C3-related peptides shows an inhibitory effect on the enzyme activity, whereas the association with HDL might influence its environment and/or its interaction with cells. The study of the catalytic properties shows a prominent effect on bacterial phospholipids, synthetic phosphatidylethanolamine, and membranes from U937 monoblasts, but not on synthetic phosphatidylcholine or on PMNs, even when these cells were maintained in culture to allow spontaneous apoptosis and became a good substrate for pancreatic type PLA2.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7864806      PMCID: PMC1136497          DOI: 10.1042/bj3060167

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  63 in total

1.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

2.  Purification and characterization of rabbit platelet cytosolic phospholipase A2.

Authors:  D K Kim; I Kudo; K Inoue
Journal:  Biochim Biophys Acta       Date:  1991-04-24

3.  Differentiation-dependent expression of phosphatidylserine in mammalian plasma membranes: quantitative assessment of outer-leaflet lipid by prothrombinase complex formation.

Authors:  J Connor; C Bucana; I J Fidler; A J Schroit
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

4.  The primary structure of a membrane-associated phospholipase A2 from human spleen.

Authors:  A Kanda; T Ono; N Yoshida; H Tojo; M Okamoto
Journal:  Biochem Biophys Res Commun       Date:  1989-08-30       Impact factor: 3.575

5.  The Ca2(+)-sensitive cytosolic phospholipase A2 is a 100-kDa protein in human monoblast U937 cells.

Authors:  R M Kramer; E F Roberts; J Manetta; J E Putnam
Journal:  J Biol Chem       Date:  1991-03-15       Impact factor: 5.157

6.  Purification of a cellular (granulocyte) and an extracellular (serum) phospholipase A2 that participate in the destruction of Escherichia coli in a rabbit inflammatory exudate.

Authors:  G W Wright; C E Ooi; J Weiss; P Elsbach
Journal:  J Biol Chem       Date:  1990-04-25       Impact factor: 5.157

7.  Genetic heterogeneity of lipoproteins in inbred strains of mice: analysis by gel-permeation chromatography.

Authors:  S Jiao; T G Cole; R T Kitchens; B Pfleger; G Schonfeld
Journal:  Metabolism       Date:  1990-02       Impact factor: 8.694

Review 8.  Role of phospholipase in generating lipid second messengers in signal transduction.

Authors:  E A Dennis; S G Rhee; M M Billah; Y A Hannun
Journal:  FASEB J       Date:  1991-04       Impact factor: 5.191

9.  Proteinaceous inhibitors of phospholipase A2 purified from inflammatory sites in rats.

Authors:  Y Suwa; I Kudo; A Imaizumi; M Okada; T Kamimura; Y Suzuki; H W Chang; S Hara; K Inoue
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

10.  Induction of group II-like phospholipase A2 by lipopolysaccharide in the liver of BCG-primed rat.

Authors:  M Inada; H Tojo; S Kawata; S Tarui; M Okamoto
Journal:  Biochem Biophys Res Commun       Date:  1991-02-14       Impact factor: 3.575

View more
  13 in total

1.  Circulating inflammatory mediators in patients with fever: predicting bloodstream infection.

Authors:  A B Groeneveld; A W Bossink; G J van Mierlo; C E Hack
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

2.  Secretory non-pancreatic phopholipase A2 in severe sepsis: relation to endotoxin, cytokines and thromboxane B2.

Authors:  B Guidet; O Piot; J Masliah; V Barakett; E Maury; G Bereziat; G Offenstadt
Journal:  Infection       Date:  1996 Mar-Apr       Impact factor: 3.553

3.  Secreted PLA2 induces proliferation in astrocytoma through the EGF receptor: another inflammation-cancer link.

Authors:  Marita Hernández; Rubén Martín; Miriam Daniela García-Cubillas; Patricia Maeso-Hernández; María Luisa Nieto
Journal:  Neuro Oncol       Date:  2010-07-16       Impact factor: 12.300

4.  Proteolysis of apolipoprotein A-I by secretory phospholipase A₂: a new link between inflammation and atherosclerosis.

Authors:  Giorgio Cavigiolio; Shobini Jayaraman
Journal:  J Biol Chem       Date:  2014-02-12       Impact factor: 5.157

5.  HDL remodeling during the acute phase response.

Authors:  Anisa Jahangiri; Maria C de Beer; Victoria Noffsinger; Lisa R Tannock; Chandrashekar Ramaiah; Nancy R Webb; Deneys R van der Westhuyzen; Frederick C de Beer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-11-13       Impact factor: 8.311

6.  Neutrophil effector responses are suppressed by secretory phospholipase A2 modified HDL.

Authors:  Sanja Curcic; Michael Holzer; Robert Frei; Lisa Pasterk; Rudolf Schicho; Akos Heinemann; Gunther Marsche
Journal:  Biochim Biophys Acta       Date:  2014-11-24

7.  Secretory phospholipase A2 modified HDL rapidly and potently suppresses platelet activation.

Authors:  Sanja Curcic; Michael Holzer; Lisa Pasterk; Eva Knuplez; Thomas O Eichmann; Saša Frank; Robert Zimmermann; Rudolf Schicho; Akos Heinemann; Gunther Marsche
Journal:  Sci Rep       Date:  2017-08-14       Impact factor: 4.379

Review 8.  The role of complement system in septic shock.

Authors:  Jean Charchaflieh; Jiandong Wei; Georges Labaze; Yunfang Joan Hou; Benjamin Babarsh; Helen Stutz; Haekyung Lee; Samrat Worah; Ming Zhang
Journal:  Clin Dev Immunol       Date:  2012-09-23

9.  CD64 and Group II Secretory Phospholipase A2 (sPLA2-IIA) as Biomarkers for Distinguishing Adult Sepsis and Bacterial Infections in the Emergency Department.

Authors:  Toh Leong Tan; Nurul Saadah Ahmad; Dian Nasriana Nasuruddin; Azlin Ithnin; Khaizurin Tajul Arifin; Ida Zarina Zaini; Wan Zurinah Wan Ngah
Journal:  PLoS One       Date:  2016-03-22       Impact factor: 3.240

10.  Varespladib (LY315920) Appears to Be a Potent, Broad-Spectrum, Inhibitor of Snake Venom Phospholipase A2 and a Possible Pre-Referral Treatment for Envenomation.

Authors:  Matthew Lewin; Stephen Samuel; Janie Merkel; Philip Bickler
Journal:  Toxins (Basel)       Date:  2016-08-25       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.